PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Non-Melanoma Skin Cancer is diagnosed in approximately 3.3 million people in the U.S. annually. Of Those Total NMSC Diagnoses, approximately 80% are Basal Cell Carcinomas– I consider basal cell carcinoma
Continue reading